Skip to main content
. 2014 Sep 15;7(10):6644–6652.

Table 2.

Relationships between mean SWV and clinicopathologic features of 143 invasive ductal cancers

Clinicopathologic features < 3.30 m/s 3.30-7.03 m/s ≥ 7.03 m/s Mean SWV m/s Median SWV m/s
Agea
    < 50 (n = 28) 4 5 19 6.96 ± 2.33 7.69
    ≥ 50 (n = 115) 16 23 76 7.04 ± 2.41 7.72
Tumor sizeb
    < 10 mm (n = 11) 7 4 0 3.07 ± 0.73 2.99
    10-20 mm (n = 53) 10 15 28 6.30 ± 2.55 7.40
    ≥ 20 mm (n = 79) 3 9 67 8.07 ± 1.51 9.00
Lymph nodal metastasisc
    Negative (n = 89) 17 25 47 6.46 ± 2.48 7.31
    Positive (n = 54) 3 3 48 7.96 ± 1.89 9.00
Histological graded
    Grade 1 (n = 12) 5 3 4 5.38 ± 2.76 6.29
    Grade 2 (n = 86) 12 19 55 6.76 ± 2.39 7.61
    Grade 3 (n = 45) 3 6 36 7.98 ± 1.90 9.00
ER expressiona
    Negative (n = 59) 6 14 39 7.21 ± 2.21 7.73
    Positive (n = 84) 14 14 56 6.90 ± 2.51 7.71
PR expressiona
    Negative (n = 67) 8 15 44 7.18 ± 2.36 9.00
    Positive (n = 76) 12 13 51 6.90 ± 2.42 7.65
C-erbB-2 expressione
    Negative (n = 39) 11 6 22 5.58 ± 0.52 5.74
    Positive (n = 104) 9 22 73 7.30 ± 2.22 7.94

ER: estrogen receptor, PR: C-erbB-2: progesterone receptor human epidermal growth factor receptor 2, SWV: shear wave velocity.

a

P > 0.05;

b

P < 0.001;

c

P < 0.001;

d

P = 0.001;

e

P = 0.029.